VERIFY® Dual Species Self-Contained Biological Indicator, Distributed by STERIS Corporation, Mentor, OH. Intended for use in installation testing and routine monitoring of steam sterilization and ethylene oxide sterilization processes.
Publicado el 8 de enero de 2014 · Inicio del retiro: 10 de septiembre de 2013
Resumen
FDA registra el retiro Z-0605-2014 de dispositivos médicos de Clase II, publicado el 8 de enero de 2014 e iniciado el 10 de septiembre de 2013. Empresa responsable: Steris Corporation; Estado: Finalizado; Cantidad reportada: 1,238 boxes; Lote: Lot #131004 Model #'s: S3060, S3061, S3065, S3069, LCB006 & LCB007. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
STERIS has identified that the population of the G. stearothermophilus spores that monitor STEAM sterilization cycles does not meet specifications for Lot # 131004 of the Verify Dual Species Self-Contained Biological Indicators. As a result the spore count on the affected product is lower than the labeled minimum and the product may incorrectly indicate that a 5-log spore kill was achieved.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Steris Corporation
- Distribuidor
- Worldwide Distribution-USA (nationwide) including the states of AK, Al, AR, AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV and WY, and the countries of BAHRAIN, CANADA, COLUMBIA, GERMANY, ITALY, MALAYSIA, PHILIPPINES, ROMANIA, SPAIN, and THE NETHERLANDS.
- Lote
- Lot #131004 Model #'s: S3060, S3061, S3065, S3069, LCB006 & LCB007.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDARAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML02011721 de octubre de 2026
- FDARAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML02011521 de octubre de 2026
- FDARAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML02011621 de octubre de 2026
- FDAVERIFY Biological Steam Test Pack Model/Catalog Number: S306914 de octubre de 2026
- FDASTERRAD Cyclesure Biological Indicator (BI, Part No. 14324. Intended to be used as a standard method for8 de enero de 2014
- FDARTC 25-C Inline Aerosol Tee Adapter. Intended to be used to adapt an aerosolized medication delivery system8 de enero de 2014
Preguntas sobre este retiro
¿VERIFY® Dual Species Self-Contained Biological Indicator, Distributed by STERIS Corporation, Mentor, OH. Intended for use in installation testing and routine monitoring of steam sterilization and ethylene oxide sterilization processes. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0605-2014 el 8 de enero de 2014. Peligro reportado: STERIS has identified that the population of the G. stearothermophilus spores that monitor STEAM sterilization cycles does not meet specifications for Lot # 131004 of the Verify Dual Species Self-Contained Biological Indicators. As a result the spore count on the affected product is lower than the labeled minimum and the product may incorrectly indicate that a 5-log spore kill was achieved.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter